DOCSLIB.ORG

Production of High Value Drug Metabolites Using Engineered Cytochromes P450

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Production of High Value Drug Metabolites Using Engineered Cytochromes P450 Production of high value drug metabolites using engineered cytochromes P450 A thesis submitted to The University of Manchester for the degree of Doctor of Philosophy in the Faculty of Life Sciences 2013 Christopher Butler Table of Contents Title Page 1 Table of Contents 2 List of Figures 8 List of Tables 15 Abbreviations 17 Abstract 20 Declaration and Copyright statement 21 Acknowledgements 22 Preface to the alternate format thesis 23 Chapter 1 – Introduction 26 1.1 Drug metabolites 26 1.1.1 What are they? 26 1.1.2 How are they produced? 26 1.1.3 Why are they important? 27 1.1.4 The enzymes involved 28 1.1.5 Regulatory guidance 29 1.1.6 Reasons for regulation 30 1.1.7 Genetics 30 1.1.8 Current methods of metabolite synthesis 31 1.2 Cytochromes P450 32 1.2.1 Overview 32 1.2.2 Physiological roles 33 1.2.3 Heme proteins 36 1.2.4 The P450 catalytic cycle 37 1.2.5 Active species in the P450 catalytic cycle 38 1.2.6 The P450 heme iron spin state 41 1.2.7 Cytochrome P450 structures 42 1.2.8 Redox partners 43 1.2.9 P450 electron transfer reactions 46 2 1.3 P450 BM3 from Bacillus megaterium 51 1.3.1 Overview 51 1.3.2 P450 BM3 structure 53 1.4 Biotechnology 57 1.5 References 62 Chapter 2 – Title page 83 “Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias” 2.1 Summary 84 2.2 Introduction 85 2.3 Experimental Procedures 87 2.3.1 Generation, expression and purification of WT and 87 variant P450 BM3 proteins 2.3.2 Quantification of P450 BM3 enzymes and 88 determination of their substrate affinity and steady- state kinetic properties 2.3.3 Omeprazole and 5-OH omeprazole turnover and 89 analysis by LC-MS 2.3.4 Omeprazole turnover and analysis by NMR 90 2.3.5 Examination of hemoprotein stability by differential 90 scanning calorimetry 2.3.6 Crystallization of P450 BM3 heme domains and 91 determination of protein structures 2.4 Materials 92 3 2.5 Results 93 2.5.1 Characterization of omeprazole binding properties of 93 BM3 variants 2.5.2 Steady-state kinetics of P450 BM3 variants with 96 omeprazole 2.5.3 Oxidation of omeprazole by WT and variant P450 96 BM3 enzymes 2.5.4 Structural analysis of omeprazole-binding P450 BM3 100 variants 2.6 Discussion 112 2.7 Supplemental Data 116 2.7.1 Characterization of substrate and oxidized products 116 by NMR spectroscopy 2.7.2 Differential Scanning Calorimetry (DSC) 121 2.8 References 124 2.9 Footnotes 130 Chapter 3 – Title Page 131 “Human P450-like oxidative transformations of proton pump inhibitor drugs by a P450 BM3 variant that induces conformational reconfiguration of the enzyme” 3.1 Abstract 132 3.2 Introduction 133 3.3 Experimental Procedures 135 3.3.1 Mutagenesis and expression of WT and variant P450 135 BM3 enzymes 3.3.2 Purification of WT and variant intact P450 BM3 and 135 heme domains 4 3.3.3 P450 quantification 3.3.4 Substrate binding and kinetic properties of WT and 136 variant intact BM3 with fatty acids and PPI substrates 136 3.3.5 EPR spectroscopy 3.3.6 Enzymatic oxidation of substrates and product 137 characterization 137 3.3.7 Crystallization of BM3 heme domains and determination of protein structures 139 3.4 Materials 140 3.5 Results 3.5.1 Spectral binding studies 141 3.5.2 Steady state kinetics 147 3.5.3 EPR spectroscopy 151 3.5.4 Oxidation of PPI’s by WT and variant P450 BM3 157 enzymes using Liquid Chromatography Mass Spectrometry (LCMS) 3.5.5 Oxidation of PPI’s by WT and Variant P450 BM3 165 enzymes using NMR 3.5.6 X-ray crystallography 180 3.6 Discussion 184 3.7 References 187 Chapter 4 – Title Page 193 “Oxidation of diverse drug molecules by P450 BM3 gatekeeper variants” 4.1 Abstract 194 4.2 Introduction 195 5 4.3 Materials and methods 198 4.3.1 Mutagenesis and expression of WT and variant P450 198 BM3 enzymes 4.3.2 Purification of WT and variant P450 BM3 and heme 198 domains 4.3.3 P450 quantification 199 4.3.4 Thermofluor binding assay 199 4.3.5 EPR Spectroscopy 200 4.3.6 Analysis of the kinetics of substrate-dependent 200 NADPH oxidation by WT and variant intact BM3 enzymes 4.3.7 Drug turnover and analysis by LCMS 201 4.4 Materials 202 4.5 Results 203 4.5.1 Thermal unfolding of WT and variant P450 BM3 203 heme domains using a Thermofluor assay 4.5.2 Electron Paramagnetic Resonance spectrometry 205 (EPR) 4.5.3 Steady state kinetic analysis of drug-dependent 209 NADPH oxidation 4.5.4 Product identification from P450 BM3 turnover of drug 213 substrates by LCMS 4.6 Discussion 222 4.7 References 229 Chapter 5 – Summary, conclusions and 235 further work 5.1 Summary 235 6 5.2 Conclusions 245 5.3 Further Work 246 5.4 References 247 Appendix 251 7 List of Figures Chapter 1 Figure 1.1 - Simplified reaction pathway for 33 cytochromes P450 Figure 1.2 - Common P450 reaction types 34 Figure 1.3 - The major forms of heme prosthetic groups 36 Figure 1.4 - The P450 catalytic cycle 38 Figure 1.5 - The P450 radical rebound mechanism 39 Figure 1.6 - The ferric heme iron d-orbital electron state 41 in low spin and high spin configurations Figure 1.7 - General P450 structure 42 Figure 1.8 - Structures of the P450 reductase enzyme 44 cofactors Figure 1.9 - Schematic representation of the 3 major 45 P450 classes Figure 1.10 - Diagrammatic representation of flavin 46 oxidation states Figure 1.11 - The electron transfer process in type I 47 P450 systems Figure 1.12 - Electron transfer in type II P450 redox 49 systems that use CPR 8 Figure 1.13 - P450 electron transfer in type III redox 50 systems Figure 1.14 - The crystal structure of the heme domain 54 of P450 BM3 with N-palmitoylglycine (NPG) bound (PDB code 1PJZ) Chapter 2 Figure 2.1 - The structure of omeprazole 93 Figure 2.2 - Binding and oxidation of omeprazole by 95 P450 BM3 variants Figure 2.3 - LC-MS analysis of products derived from 97 omeprazole oxidation by the P450 BM3 F87V/A82F (DM) double mutant enzyme Figure 2.4 - Optical binding titration for the BM3 DM with 99 5-OH OMP Figure 2.5 - Time course of substrate oxidation and 100 product formation in the reaction of the P450 BM3 DM enzyme with omeprazole Figure 2.6 - Structures of P450 BM3 enzymes and their 101 omeprazole binding sites Figure 2.7 - Interactions of omeprazole in the active site 105 of the A82F BM3 heme domain Figure 2.8 - Stereoviews of structural overlays of 107 substrate-bound forms of the BM3 A82F- containing variant heme domains with WT BM3 9 Figure 2.9 - Structural overlay of the omeprazole-bound 109 A82F variant with the WT BM3 heme domain Figure 2.10 - Conformational equilibria and the 111 relationship with structural stability in P450 BM3 Chapter 2 – Supplemental Data Figure 2.S1 - 1H NMR spectrum of omeprazole 117 Figure 2.S2 - HMBC spectrum of omeprazole 118 Figure 2.S3 - 1H NMR spectrum of turnover products 119 from omeprazole oxidation Figure 2.S4 - HMBC spectra of turnover products from 120 omeprazole oxidation Figure 2.S5 - Graphical overlay of DSC data for WT and 123 variant BM3 heme domains Chapter 3 Figure 3.1 - Proton pump inhibitor (PPI) drug structure 141 and functional groups Figure 3.2 - Esomeprazole binding to the P450 BM3 DM 142 enzyme Figure 3.3 - Pantoprazole binding to the P450 BM3 DM 143 enzyme Figure 3.4 - Lansoprazole and rabeprazole binding to 143 the DM P450 BM3 enzyme 10 Figure 3.5 - Esomeprazole binding to the P450 BM3 144 A82F enzyme Figure 3.6 - Pantoprazole binding to the P450 BM3 145 A82F enzyme Figure 3.7 - Lansoprazole and rabeprazole binding to 145 the A82F P450 BM3 enzyme Figure 3.8 - PPI-dependent steady state kinetic analysis 148 for the A82F P450 BM3 variant Figure 3.9 - PPI-dependent steady state kinetic analysis 149 for the F87V P450 BM3 variant Figure 3.10 - PPI-dependent steady state kinetic 150 analysis for the F87V/A82F (DM) P450 BM3 Figure 3.11 - PPI-dependent steady state kinetic 151 analysis for the WT P450 BM3 with lansoprazole Figure 3.12 - EPR analysis of WT P450 BM3 heme 153 domain Figure 3.13 - EPR analysis of the A82F P450 BM3 154 heme domain Figure 3.14 - EPR analysis of the F87V BM3 heme 155 domain Figure 3.15 - EPR analysis of the DM P450 BM3 heme 156 domain Figure 3.16 - Reactions schemes outlining pathways of 157 P450 metabolism of PPI drugs 11 Figure 3.17 - LC-MS traces of esomeprazole turnover 158 by the P450 BM3 DM enzyme Figure 3.18 - LC-MS traces for lansoprazole turnover by 160 the P450 BM3 DM enzyme Figure 3.19 - LC-MS traces showing pantoprazole 161 turnover from the P450 BM3 DM enzyme Figure 3.20 - LC-MS traces for rabeprazole turnover by 163 BM3 enzymes Figure 3.21 - Proportions of PPI turnover products 165 identified by LCMS Figure 3.22 - 1H NMR spectrum of esomeprazole 167 Figure 3.23 - HMBC spectrum of esomeprazole 168 Figure 3.24 - 1H NMR spectrum of turnover products 169 from esomeprazole oxidation Figure 3.25 - HMBC spectra of turnover products from 170 esomeprazole oxidation Figure 3.26 - 1H NMR spectrum of lansoprazole 172 Figure 3.27 - 1H NMR spectrum of the lansoprazole 173 sulfone standard Figure 3.28 - 1H NMR spectrum of turnover products 174 from lansoprazole oxidation Figure 3.29 - 1H NMR spectrum of rabeprazole 176 Figure 3.30 - COSY NMR spectrum of rabeprazole 177 12 Figure 3.31 - HMBC spectrum of rabeprazole 178 Figure 3.32 - 1H NMR spectrum of turnover products 179 from rabeprazole (100 µM) oxidation Figure 3.33 - 1H NMR spectrum of turnover products 180 from rabeprazole (50 µM) oxidation Figure 3.34 - Overlay of the DM BM3 heme domain 182 esomeprazole crystal structure with the previously reported DM omeprazole structure (4KEY) Figure 3.35 - Figure 3.35 Density overlay of the 183 pantoprazole-bound DM heme domain crystal structure with the esomeprazole-bound DM heme domain structure.
Load more

Recommended publications
  • Potential for and Distribution of Enzymatic Biodegradation of Polystyrene by Environmental Microorganisms
    materials Communication Potential for and Distribution of Enzymatic Biodegradation of Polystyrene by Environmental Microorganisms Liyuan Hou and Erica L.-W. Majumder * Department of Chemistry, SUNY College of Environmental Science and Forestry, Syracuse, NY 13210, USA; [email protected] * Correspondence: [email protected] or [email protected]; Tel.: +1-3154706854 Abstract: Polystyrene (PS) is one of the main polymer types of plastic wastes and is known to be resistant to biodegradation, resulting in PS waste persistence in the environment. Although previous studies have reported that some microorganisms can degrade PS, enzymes and mechanisms of microorganism PS biodegradation are still unknown. In this study, we summarized microbial species that have been identified to degrade PS. By screening the available genome information of microorganisms that have been reported to degrade PS for enzymes with functional potential to depolymerize PS, we predicted target PS-degrading enzymes. We found that cytochrome P4500s, alkane hydroxylases and monooxygenases ranked as the top potential enzyme classes that can degrade PS since they can break C–C bonds. Ring-hydroxylating dioxygenases may be able to break the side-chain of PS and oxidize the aromatic ring compounds generated from the decomposition of PS. These target enzymes were distributed in Proteobacteria, Actinobacteria, Bacteroidetes, and Firmicutes, suggesting a broad potential for PS biodegradation in various earth environments and microbiomes. Our results provide insight into the enzymatic degradation of PS and suggestions for realizing the biodegradation of this recalcitrant plastic. Citation: Hou, L.; Majumder, E.L. Keywords: plastics; polystyrene biodegradation; enzymatic biodegradation; monooxygenase; alkane Potential for and Distribution of hydroxylase; cytochrome P450 Enzymatic Biodegradation of Polystyrene by Environmental Microorganisms.
    [Show full text]
  • Flavoprotein Hydroxylases and Epoxidases
    277 Flavins on the Move: Flavoprotein Hydroxylases and Epoxidases Willem J.H. van Berkel1, Stefania Montersino1, Dirk Tischler2, Stefan Kaschabek2, Michael Schlömann2, George T. Gassner3 1Laboratory of Biochemistry, Wageningen University, Wageningen, The Netherlands 2Environmental Microbiology, TU Bergakademie Freiberg, Germany 3Department of Chemistry and Biochemistry, San Francisco State University, San Francisco, USA Introduction Flavoprotein monooxygenases perform chemo-, regio- and/or enantioselective oxygenations of organic substrates under mild reaction conditions [1]. These properties along with effective preparation methods turn flavoprotein monooxygenases in focus of industrial biocatalysis. Here we describe two biocatalytically relevant subclasses of flavoprotein monooxygenases with a close evolutionary relation: class A represented by p-hydroxybenzoate hydroxylase (PHBH) and class E formed by styrene monooxygenases (SMOs). PHBH family members perform highly regioselective hydroxylations on a wide variety of aromatic compounds. A rapid increase in available crystal structures and detailed mechanistic studies of such enzymes [2] are opening a new season of research in the field. SMOs catalyze a number of stereoselective epoxidation and sulfoxidation reactions [3]. Mechanistic and structural studies expose distinct characteristics, which provide a promising source for future biocatalyst development [4]. Nearly all bacterial SMOs are two- component proteins comprising a reductase and a monooxygenase. Remarkably, in few cases, the reductase is fused to the monooxygenase [5]. Such a self-sufficient enzyme can also cooperate with a single monooxygenase, resulting in a novel type of two-component SMO [6]. Results & Discussion Flavoprotein monooxygenases can be divided in six different subclasses based on structural features and oxygenation chemistry [1]. Table 1 gives an overview of the crystal structures of single-component flavoprotein aromatic hydroxylases (class A) and two-component styrene monooxygenases (SMO; class E).
    [Show full text]
  • An Overview of Microbial Indigo-Forming Enzymes
    Applied Microbiology and Biotechnology (2020) 104:925–933 https://doi.org/10.1007/s00253-019-10292-5 MINI-REVIEW An overview of microbial indigo-forming enzymes Andrea N. Fabara1 & Marco W. Fraaije1 Received: 11 October 2019 /Revised: 23 November 2019 /Accepted: 28 November 2019 /Published online: 13 December 2019 # The Author(s) 2019 Abstract Indigo is one of the oldest textile dyes and was originally prepared from plant material. Nowadays, indigo is chemically synthesized at a large scale to satisfy the demand for dyeing jeans. The current indigo production processes are based on fossil feedstocks; therefore, it is highly attractive to develop a more sustainable and environmentally friendly biotechnological process for the production of this popular dye. In the past decades, a number of natural and engineered enzymes have been identified that can be used for the synthesis of indigo. This mini-review provides an overview of the various microbial enzymes which are able to produce indigo and discusses the advantages and disadvantages of each biocatalytic system. Keywords Indigo . Indole . Naphthalene dioxygenase . Styrene monoxygenase . P450 monoxygenase . Peroxygenase . Flavoprotein monooxygenase Introduction vats, hence the classification as a vat-dye. The deposition of the insoluble indigo on the fabric results in a special decora- Humans have decorated textiles with dyes and pigments, often tion of the fabric material as the fabric is not penetrated by the derived from plant material, since ancient times (Aino et al. dye. This gives denim and other indigo-dyed garments their 2018). Indigo blue (in short: indigo) is one of the oldest dyes special appearance, where wear or abrasion exposes the white to be used for textile dyeing (Fig.
    [Show full text]
  • Relating Metatranscriptomic Profiles to the Micropollutant
    1 Relating Metatranscriptomic Profiles to the 2 Micropollutant Biotransformation Potential of 3 Complex Microbial Communities 4 5 Supporting Information 6 7 Stefan Achermann,1,2 Cresten B. Mansfeldt,1 Marcel Müller,1,3 David R. Johnson,1 Kathrin 8 Fenner*,1,2,4 9 1Eawag, Swiss Federal Institute of Aquatic Science and Technology, 8600 Dübendorf, 10 Switzerland. 2Institute of Biogeochemistry and Pollutant Dynamics, ETH Zürich, 8092 11 Zürich, Switzerland. 3Institute of Atmospheric and Climate Science, ETH Zürich, 8092 12 Zürich, Switzerland. 4Department of Chemistry, University of Zürich, 8057 Zürich, 13 Switzerland. 14 *Corresponding author (email: [email protected] ) 15 S.A and C.B.M contributed equally to this work. 16 17 18 19 20 21 This supporting information (SI) is organized in 4 sections (S1-S4) with a total of 10 pages and 22 comprises 7 figures (Figure S1-S7) and 4 tables (Table S1-S4). 23 24 25 S1 26 S1 Data normalization 27 28 29 30 Figure S1. Relative fractions of gene transcripts originating from eukaryotes and bacteria. 31 32 33 Table S1. Relative standard deviation (RSD) for commonly used reference genes across all 34 samples (n=12). EC number mean fraction bacteria (%) RSD (%) RSD bacteria (%) RSD eukaryotes (%) 2.7.7.6 (RNAP) 80 16 6 nda 5.99.1.2 (DNA topoisomerase) 90 11 9 nda 5.99.1.3 (DNA gyrase) 92 16 10 nda 1.2.1.12 (GAPDH) 37 39 6 32 35 and indicates not determined. 36 37 38 39 S2 40 S2 Nitrile hydration 41 42 43 44 Figure S2: Pearson correlation coefficients r for rate constants of bromoxynil and acetamiprid with 45 gene transcripts of ECs describing nucleophilic reactions of water with nitriles.
    [Show full text]
  • Electron Transfer Partners of Cytochrome P450
    4 Electron Transfer Partners of Cytochrome P450 Mark J.l. Paine, Nigel S. Scrutton, Andrew W. Munro, Aldo Gutierrez, Gordon C.K. Roberts, and C. Roland Wolf 1. Introduction Although P450 redox partners are usually expressed independently, "self-sufficient" P450 monooxygenase systems have also evolved through Cytochromes P450 contain a heme center the fusion of P450 and CPR genes. These fusion where the activation of molecular oxygen occurs, molecules are found in bacteria and fungi, the best- resulting in the insertion of a single atom of known example being P450 BM3, a fatty acid oxygen into an organic substrate with the con­ (0-2 hydroxylase from Bacillus megaterium, which comitant reduction of the other atom to water. The comprises a soluble P450 with a fiised carboxyl- monooxygenation reaction requires a coupled and terminal CPR module (recently reviewed by stepwise supply of electrons, which are derived Munro^). BM3 has the highest catalytic activity from NAD(P)H and supplied via a redox partner. known for a P450 monooxygenase^ and was for P450s are generally divided into two major classes many years the only naturally occurring ftised sys­ (Class I and Class II) according to the different tem known until the identification of a eukaryotic types of electron transfer systems they use. P450s membrane-bound equivalent fatty acid hydroxy­ in the Class I family include bacterial and mito­ lase, CYP505A1, from the phytopathogenic fungus chondrial P450s, which use a two-component Fusarium oxysporurrP. A number of novel P450 sys­ shuttle system consisting of an iron-sulfur protein tems are starting to emerge from the large numbers (ferredoxin) and ferredoxin reductase (Figure 4.1).
    [Show full text]
  • UC Berkeley UC Berkeley Electronic Theses and Dissertations
    UC Berkeley UC Berkeley Electronic Theses and Dissertations Title Oriented Attachment of Cytochrome P450 2C9 to a Self-Assembled Monolayer on a Gold Electrode as a Biosensor Design Permalink https://escholarship.org/uc/item/1m67k8mm Author Schneider, Elizabeth Publication Date 2011 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California Oriented Attachment of Cytochrome P450 2C9 to a Self-Assembled Monolayer on a Gold Electrode as a Biosensor Design by Elizabeth Ann Schneider A dissertation submitted in partial satisfaction of the requirements for the degree of Joint Doctor of Philosophy with the University of California, San Francisco in Bioengineering in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Douglas S. Clark, Chair Associate Professor Shuvo Roy Professor Liwei Lin Dr. Robert Kostecki Fall 2011 Abstract Oriented Attachment of Cytochrome P450 2C9 to a Self-Assembled Monolayer on a Gold Electrode as a Biosensor Design by Elizabeth Ann Schneider Doctor of Philosophy in Bioengineering University of California, Berkeley Professor Douglas S. Clark, Chair Cytochrome P450s (CYPs) are a family of enzymes implicated in the metabolism of drugs in the body. Consequently, P450 reactions are of high interest to the pharmaceutical industry, where lead compounds in drug development are screened as potential substrates of CYPs. The P450 reaction involves electron transfer to an iron heme via NADPH and the electron transfer partner enzyme P450 reductase (CPR). By immobilizing CYPs on an electrode however, NADPH and CPR are potentially no longer needed and the immobilized CYP can act as a biosensor by accepting electrons directly from the electrode.
    [Show full text]
  • An Overview of Microbial Indigo-Forming Enzymes Fabara, Andrea N.; Fraaije, Marco W
    University of Groningen An overview of microbial indigo-forming enzymes Fabara, Andrea N.; Fraaije, Marco W. Published in: Applied Microbiology and Biotechnology DOI: 10.1007/s00253-019-10292-5 IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2020 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Fabara, A. N., & Fraaije, M. W. (2020). An overview of microbial indigo-forming enzymes. Applied Microbiology and Biotechnology, 104(3), 925-933. https://doi.org/10.1007/s00253-019-10292-5 Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.
    [Show full text]
  • Structure-Based Redesign of a Self-Sufficient Flavin-Containing Monooxygenase Towards Indigo Production Lončar, Nikola; Van Beek, Hugo L.; Fraaije, Marco W
    University of Groningen Structure-Based Redesign of a Self-Sufficient Flavin-Containing Monooxygenase towards Indigo Production Lončar, Nikola; van Beek, Hugo L.; Fraaije, Marco W. Published in: International Journal of Molecular Sciences DOI: 10.3390/ijms20246148 IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2019 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Lonar, N., van Beek, H. L., & Fraaije, M. W. (2019). Structure-Based Redesign of a Self-Sufficient Flavin- Containing Monooxygenase towards Indigo Production. International Journal of Molecular Sciences, 20(24). https://doi.org/10.3390/ijms20246148 Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 13-01-2020 International Journal of Molecular Sciences Article Structure-Based Redesign of a Self-Sufficient Flavin-Containing Monooxygenase towards Indigo Production 1, 2, 2, Nikola Lonˇcar y, Hugo L.
    [Show full text]
  • Engineering of Cytochrome P450s CYP109E1 and CYP109A2 from Bacillus Megaterium DSM319 for The
    Engineering of Cytochrome P450s CYP109E1 and CYP109A2 from Bacillus megaterium DSM319 for the production of vitamin D3 metabolites Kumulative Dissertation zur Erlangen des Grades des Doktors der Naturwissenschaften der Naturwissenschaftlich-Technischen Fakultät der Universität des Saarlandes von Ammar Abdulmughni Saarbrücken 2018 Tag des Kolloquiums : 14.08.2018 Dekan : Prof. Dr. Guido Kickelbick Berichterstatter : Prof. Dr. Rita Bernhardt Prof. Dr. Gert-Wieland Kohring Vorsitz : Prof. Dr. Uli Müller Akad. Mitarbeiter: Dr. Ing. Michael Kohlstedt Abstract Active vitamin D3 metabolites play an essential role in the maintenance of calcium and phosphorus homeostasis. The conventional chemical synthesis of this metabolite is time- consuming, environmentally unfriendly and often results in low yield. Therefore, the biotechnological production of active vitamin D3 metabolites is of great importance to the pharmaceutical industry. Hereby, cytochrome P450 enzymes have the potential to achieve this goal. The present work reports on the optimization of a biotechnological process in Bacillus megaterium MS941 for the production of vitamin D3 metabolites. On that account, two cytochrome P450 enzymes were used as biocataylsts, namely CYP109E1 and CYP109A2 from the Gram-positive bacterium Bacillus megaterium DSM319. Both enzymes were subjected for functional and structural characterization in order to optimize their activity and/or regio-selectivity towards vitamin D3. In terms of hydroxylation activity, it has been shown that the conversion of vitamin D3 with CYP109E1 results in the formation of several derivatives, while CYP109A2 shows clearly a higher regio-selectivity towards 25- hydroxylation. The elucidation of the crystal structure of both enzymes provides detailed insights into the geometry of these enzymes. By means of molecular docking, site-directed mutagenesis was successfully performed, resulting in the creation of mutants with higher regio-selectivity compared to the wild type, in particular when using CYP109E1.
    [Show full text]
  • Flavoprotein Monooxygenases for Oxidative Biocatalysis: Recombinant Expression in Microbial Hosts and Applications
    REVIEW ARTICLE published: 06 February 2014 doi: 10.3389/fmicb.2014.00025 Flavoprotein monooxygenases for oxidative biocatalysis: recombinant expression in microbial hosts and applications Romina D. Ceccoli 1, Dario A. Bianchi 2 and Daniela V. Rial 1* 1 Área Biología Molecular, Departamento de Ciencias Biológicas, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario;CONICET, Rosario, Argentina 2 Instituto de Química Rosario (IQUIR, CONICET-UNR), Área Análisis de Medicamentos, Departamento de Química Orgánica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina Edited by: External flavoprotein monooxygenases comprise a group of flavin-dependent Eduardo A. Ceccarelli, Universidad oxidoreductases that catalyze the insertion of one atom of molecular oxygen into Nacional de Rosario, Argentina an organic substrate and the second atom is reduced to water. These enzymes are Reviewed by: involved in a great number of metabolic pathways both in prokaryotes and eukaryotes. Pablo D. De Maria, Sustainable Momentum, Spain Flavoprotein monooxygenases have attracted the attention of researchers for several Vicente Gotor-Fernández, decades and the advent of recombinant DNA technology caused a great progress in the Universidad de Oviedo, Spain field. These enzymes are subjected to detailed biochemical and structural characterization *Correspondence: and some of them are also regarded as appealing oxidative biocatalysts for the production Daniela V. Rial, Área Biología of fine chemicals
    [Show full text]
  • Conformational Changes in Binding of Substrates with Human Cytochrome P450 Enzymes
    Book of oral abstracts 100 Conformational changes in binding of substrates with human cytochrome P450 enzymes F. Peter Guengerich, Clayton J. Wilkey, Michael J. Reddish, Sarah M. Glass, and Thanh T. N. Phan Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA Introduction. Extensive evidence now exists that P450 enzymes can exist in multiple conformations, at least in the substrate-bound forms (e.g., crystallography). This multiplicity can be the result of either an induced fit mechanism or conformational selection (selective substrate binding to one of two or more equilibrating P450 conformations). Aims. Kinetic approaches can be used to distinguish between induced fit and conformational selection models. The same energy is involved in reaching the final state, regardless of the kinetic path. Methods. Stopped-flow absorbance and fluorescence measurements were made with recombinant human P450 enzymes. Analysis utilized kinetic modeling software (KinTek Explorer®). Results. P450 17A1 binding to its steroid ligands (pregnenolone and progesterone and the 17-hydroxy derivatives) is dominated by a conformational selection process, as judged by (a) decreasing rates of substrate binding as a function of substrate concentration, (b) opposite patterns of the dependence of binding rates as a function of varying concentrations of (i) substrate and (ii) enzyme, and (c) modeling of the data in KinTek Explorer. The inhibitory drugs orteronel and abiraterone bind P450 17A1 in multi-step processes, apparently in different ways. The dye Nile Red is also a substrate for P450 17A1 and its sequential binding to the enzyme can be resolved in fluorescence and absorbance changes. P450s 2C8, 2D6, 2E1, and 4A11 have also been analyzed with regard to substrate binding and utilize primarily conformational selection models, as revealed by analysis of binding rates vs.
    [Show full text]
  • Optimization of the Bacterial Cytochrome P450 BM3 System for the Production of Human Drug Metabolites
    Int. J. Mol. Sci. 2012, 13, 15901-15924; doi:10.3390/ijms131215901 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Optimization of the Bacterial Cytochrome P450 BM3 System for the Production of Human Drug Metabolites Giovanna Di Nardo and Gianfranco Gilardi * Department of Life Sciences and Systems Biology, University of Torino, via Accademia Albertina 13, 10123 Torino, Italy; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +39-011-670-4593; Fax: +39-011-670-4643. Received: 27 September 2012; in revised form: 1 November 2012 / Accepted: 13 November 2012 / Published: 28 November 2012 Abstract: Drug metabolism in human liver is a process involving many different enzymes. Among them, a number of cytochromes P450 isoforms catalyze the oxidation of most of the drugs commercially available. Each P450 isoform acts on more than one drug, and one drug may be oxidized by more than one enzyme. As a result, multiple products may be obtained from the same drug, and as the metabolites can be biologically active and may cause adverse drug reactions (ADRs), the metabolic profile of a new drug has to be known before this can be commercialized. Therefore, the metabolites of a certain drug must be identified, synthesized and tested for toxicity. Their synthesis must be in sufficient quantities to be used for metabolic tests. This review focuses on the progresses done in the field of the optimization of a bacterial self-sufficient and efficient cytochrome P450, P450 BM3 from Bacillus megaterium, used for the production of metabolites of human enzymes.
    [Show full text]